Corient Private Wealth LP Makes New $1.98 Million Investment in Maximus, Inc. $MMS

Corient Private Wealth LP bought a new stake in Maximus, Inc. (NYSE:MMS) during the second quarter, HoldingsChannel.com reports. The firm bought 36,910 shares of the health services provider’s stock, valued at approximately $1,984,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Royal Bank of Canada raised its holdings in shares of Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after buying an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after buying an additional 11,754 shares in the last quarter. Jane Street Group LLC boosted its stake in Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after buying an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Maximus in the second quarter valued at about $204,000. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on MMS. Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Zacks Research cut shares of Maximus from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. Finally, Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Maximus presently has a consensus rating of “Reduce”.

Maximus Stock Up 0.1%

Shares of MMS opened at $57.67 on Thursday. Maximus, Inc. has a 52 week low of $52.73 and a 52 week high of $100.00. The stock has a market capitalization of $3.02 billion, a price-to-earnings ratio of 8.52 and a beta of 0.59. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The stock has a fifty day moving average of $57.78 and a 200-day moving average of $63.16.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the previous year, the company posted $2.16 EPS. Maximus’s quarterly revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, sell-side analysts anticipate that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Friday, August 14th. Maximus’s payout ratio is 19.50%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.